Kimberly-Clark Corporation (NASDAQ:KMB) is included among the 15 Best Boring Dividend Stocks to Buy.
On November 13, Argus analyst John Staszak upgraded Kimberly-Clark Corporation to a Buy rating from Hold and set a $120 price target, according to a report by The Fly. He pointed out that the stock has been lagging lately, but the company posted better-than-expected third quarter earnings and announced plans to acquire Kenvue, a deal expected to be completed in the second half of next year.
Kenvue became a standalone company a little over two years ago after separating from Johnson & Johnson. It focuses on consumer health and owns well-known brands such as Band-Aid, Johnson’s, Listerine, Neutrogena, Aveeno, and Tylenol. Both Kenvue and Kimberly-Clark Corporation operate in product categories that tend to remain resilient even in slower economic periods, which makes KMB an appealing value pick for long-term investors.
Kimberly-Clark Corporation earns most of its revenue through direct sales to retailers, distributors, and online platforms. The company has a broad global footprint serving both consumer and professional markets. Its customer base includes supermarkets, big-box stores, drugstores, warehouse clubs, and institutional buyers in areas such as manufacturing, hospitality, and public facilities.
READ NEXT: 15 Best Long Term Stocks to Buy According to Reddit and 15 Best Stocks to Buy for Medium Term
